United States Point-of-Care Testing Devices Market valuation $101.51 billion by 2033 - Exclusive Report by DatamIntelligence

"The Global Point-of-Care Testing Devices Market reached US$49.73 billion in 2024 and is expected to reach US$101.51 billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033" As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/point-of-care-testing-devices-market?sp

United States: Recent Industry Developments

✅ In October 2025, Abbott launched a new portable point-of-care testing device for infectious diseases. The device delivers rapid results within minutes. It is designed for clinics, emergency rooms, and remote healthcare settings.

✅ In September 2025, Roche Diagnostics introduced a compact POC platform for cardiovascular biomarker testing. The system integrates AI analytics for quick interpretation. It supports clinicians in making timely treatment decisions.

✅ In August 2025, Quidel Corporation rolled out a handheld POC testing device for respiratory pathogens. The device provides accurate results with minimal sample preparation. It enhances testing capabilities in urgent care and primary care settings.

✅ In July 2025, Siemens Healthineers launched an integrated POC testing solution combining multiple assays on a single device. The system reduces turnaround time and improves workflow. It targets hospitals and large outpatient facilities.

Japan: Recent Industry Developments

✅ In October 2025, Fujirebio launched a point-of-care immunoassay device for rapid infectious disease screening. The device delivers accurate results in under 15 minutes. It is designed for clinics and community healthcare centers.

✅ In September 2025, Sysmex Japan introduced a compact POC hematology analyzer for bedside testing. The system provides quick blood count results. It enhances patient management in hospitals and outpatient care.

✅ In August 2025, Terumo Japan deployed a handheld POC testing device for metabolic and cardiac markers. The device supports rapid clinical decision-making. It is suitable for emergency care and mobile clinics.

✅ In July 2025, Canon Medical Systems launched an AI-integrated POC diagnostic platform. The device offers multi-parameter testing with real-time results. It aims to improve efficiency and accuracy in patient care.

Point-of-Care Testing Devices Market: Drivers

The point-of-care (POC) testing devices market is experiencing strong growth as healthcare providers and patients increasingly demand rapid, on-site diagnostic solutions for improved clinical decision-making. POC devices, including glucometers, blood gas analyzers, infectious disease tests, and cardiac markers, allow immediate testing and results at clinics, hospitals, and even home settings, reducing turnaround time and enabling timely treatment. Rising prevalence of chronic diseases, infectious diseases, and acute medical conditions is driving demand for these convenient and accurate diagnostic tools. Additionally, growing adoption of decentralized healthcare models, home-based care, and telemedicine is further supporting market expansion. Technological advancements, regulatory support, and awareness of early diagnosis benefits are boosting adoption across healthcare settings.

Innovations in microfluidics, biosensors, digital integration, and connectivity with smartphones and electronic health records are enhancing the accuracy, usability, and data management capabilities of POC testing devices. Collaborations between diagnostic manufacturers, healthcare providers, and research institutions are fostering product innovation and validation. Increasing focus on personalized medicine, rapid diagnostics during pandemics, and emergency care is driving further adoption. Expansion of distribution networks, including pharmacies, clinics, and online platforms, is improving accessibility for patients and healthcare providers. With continuous technological advancements and rising demand for rapid, decentralized diagnostics, the point-of-care testing devices market is poised for sustained global growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/point-of-care-testing-devices-market?sp

Point-of-Care Testing Devices Market: Major Players

Abbott, F. Hoffmann-La Roche, BD, Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, SEKISUI Diagnostics, Trinity Biotech, Beckman Coulter, Inc., Nova Biomedical among others.

Segment Covered in the Point-of-Care Testing Devices Market:

By Product:
Includes glucose monitoring, infectious disease testing, pregnancy and fertility, tumor marker, and hematology testing products. Glucose monitoring dominates due to widespread diabetes management. Growing demand for rapid and home-based testing enhances adoption.

By Application:
Covers blood transfusion, cardiac monitoring, glucose testing, hematology, and SPO2/CO2 monitoring. Blood glucose and cardiac applications lead due to chronic disease prevalence. Non-invasive technologies improve patient comfort and accuracy.

By Testing Type:
Comprises immunoassays, cell-based assays, nucleic acid amplification, clinical chemistry, and hematology tests. Immunoassays dominate for their speed and accuracy. Molecular testing is rapidly growing for early infectious disease detection.

By Distribution Channel:
Includes hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies hold the largest share due to clinical reliability. Online channels are rapidly expanding, driven by consumer convenience and telehealth integration.

Regional Analysis

North America:
Leads the market with advanced healthcare systems and high adoption of portable diagnostic tools. The U.S. dominates due to strong presence of key manufacturers. Growing home diagnostics trend supports steady regional growth.

Europe:
Shows strong growth supported by government initiatives for rapid testing and preventive care. Germany and the U.K. lead in innovation and device approvals. Increasing demand for decentralized healthcare boosts market share.

Asia-Pacific:
Fastest-growing region due to rising healthcare expenditure and infectious disease burden. China, Japan, and India drive market expansion. Government support for digital diagnostics accelerates adoption.

South America:
Experiences gradual growth led by Brazil and Argentina. Expanding healthcare infrastructure and public awareness initiatives boost adoption. Rising chronic disease cases fuel point-of-care testing demand.

Middle East & Africa:
Emerging region with growing investments in healthcare modernization. Adoption increases through mobile health clinics and government screening programs. Affordability and awareness initiatives sustain market growth.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=point-of-care-testing-devices-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.